{"<h3>Importance</h3>": [0], "Multiple": [1, 33], "myeloma": [2, 34, 87, 279], "is": [3, 35, 221, 253], "a": [4, 185, 203], "hematologic": [5], "malignancy": [6], "characterized": [7], "by": [8, 250, 296], "presence": [9], "of": [10, 79, 82, 90, 168, 189, 202, 205, 227, 234, 255], "abnormal": [11], "clonal": [12], "plasma": [13, 145], "cells": [14], "in": [15, 37, 43, 47, 141, 152, 267], "the": [16, 44, 77, 133, 268, 311], "bone": [17, 26, 68], "marrow,": [18], "with": [19, 58, 84, 105, 115, 143, 194, 223, 231, 243, 277, 284, 298, 307], "potential": [20], "for": [21, 257, 316], "uncontrolled": [22], "growth": [23], "causing": [24], "destructive": [25], "lesions,": [27], "kidney": [28, 74], "injury,": [29], "anemia,": [30, 64], "and": [31, 46, 70, 96, 111, 138, 156, 162, 181, 218, 220, 261, 270, 293, 304], "hypercalcemia.": [32], "diagnosed": [36, 276], "an": [38, 206, 212, 285, 289], "estimated": [39, 159], "34": [40, 264], "920": [41, 265], "people": [42, 51, 266, 273], "US": [45, 269], "approximately": [48, 61], "588": [49], "161": [50], "worldwide": [52, 274], "each": [53, 280], "year.": [54, 281], "<h3>Observations</h3>": [55], "Among": [56, 191], "patients": [57, 83, 169, 183, 193], "multiple": [59, 86, 179, 195, 278], "myeloma,": [60, 180, 196], "73%": [62], "have": [63, 66, 72, 184], "79%": [65], "osteolytic": [67], "disease,": [69], "19%": [71], "acute": [73], "injury": [75], "at": [76], "time": [78], "presentation.": [80], "Evaluation": [81], "possible": [85], "includes": [88], "measurement": [89], "hemoglobin,": [91], "serum": [92, 94, 97, 102, 134], "creatinine,": [93], "calcium,": [95], "free": [98], "light": [99], "chain": [100], "levels;": [101], "protein": [103, 109], "electrophoresis": [104], "immunofixation;": [106], "24-hour": [107], "urine": [108], "electrophoresis;": [110], "full-body": [112], "skeletal": [113], "imaging": [114], "computed": [116], "tomography,": [117, 120], "positron": [118], "emission": [119], "or": [121], "magnetic": [122], "resonance": [123], "imaging.": [124], "The": [125], "Revised": [126, 174], "International": [127, 175], "Staging": [128, 176], "System": [129], "combines": [130], "data": [131], "from": [132], "biomarkers": [135], "\u03b2<sub>2</sub>microglobulin,": [136], "albumin,": [137], "lactate": [139], "dehydrogenase": [140], "conjunction": [142], "malignant": [144], "cell": [146, 247, 302], "genomic": [147], "features": [148], "found": [149], "on": [150], "fluorescence": [151], "situ": [153], "hybridization\u2014t(4;14),": [154], "del(17p),": [155], "t(14;16)\u2014to": [157], "assess": [158], "progression-free": [160, 225], "survival": [161, 188, 226], "overall": [163], "survival.": [164], "At": [165], "diagnosis,": [166], "28%": [167], "are": [170, 275, 309], "classified": [171], "as": [172], "having": [173], "stage": [177], "I": [178], "these": [182], "median": [186, 224], "5-year": [187], "82%.": [190], "all": [192], "standard": [197, 254, 314], "first-line": [198], "(induction)": [199], "therapy": [200, 241, 283, 306], "consists": [201], "combination": [204], "injectable": [207, 286], "proteasome": [208, 287], "inhibitor": [209], "(ie,": [210, 216], "bortezomib),": [211], "oral": [213, 290], "immunomodulatory": [214, 291], "agent": [215, 292], "lenalidomide),": [217], "dexamethasone": [219, 294], "associated": [222], "41": [228], "months,": [229], "compared": [230], "historical": [232], "reports": [233], "8.5": [235], "months": [236], "without": [237], "therapy.": [238], "This": [239], "induction": [240], "combined": [242], "autologous": [244, 299], "hematopoietic": [245, 300], "stem": [246, 301], "transplantation": [248], "followed": [249, 295], "maintenance": [251, 305], "lenalidomide": [252, 308], "care": [256, 315], "eligible": [258, 317], "patients.": [259, 318], "<h3>Conclusions": [260], "Relevance</h3>": [262], "Approximately": [263], "155": [271], "688": [272], "Induction": [282], "inhibitor,": [288], "treatment": [297], "transplantation,": [303], "among": [310], "treatments": [312], "considered": [313]}